Rho T1 Inhibitors
The chemical class of Rho T1 inhibitors represents a diverse array of compounds that indirectly modulate the activity of Rho T1 by targeting various signaling pathways and cellular processes associated with Rho T1 function. These inhibitors act through different mechanisms, influencing Rho T1 activity by altering the upstream or downstream signaling elements of the pathways in which Rho T1 is involved. Y-27632 and HA-1077 (Fasudil) exemplify this class by inhibiting ROCK, a downstream effector of Rho. The inhibition of ROCK affects the actin cytoskeleton dynamics and cell motility, which are crucial for the functional expression of Rho T1. Similarly, CCG-1423, targeting the Rho/MRTF/SRF transcription pathway, and Rhosin, inhibiting Rho-GEF interaction, demonstrate the indirect approach of modulating Rho T1 activity. These compounds achieve inhibition by disrupting the gene expression regulated by Rho and blocking Rho activation, respectively.
Other notable compounds in this class include NSC23766 and ITX3, which inhibit the interaction between Rho and specific GEFs like Trio and Tiam1, thereby disrupting Rho signaling pathways that could indirectly modulate Rho T1. ML141 and CASIN, inhibitors of Cdc42, further illustrate the indirect approach by influencing Rho-mediated signaling pathways, altering actin organization, and cell morphology which are key in Rho T1 regulation. Additionally, Toxin B provides a unique mechanism by inactivating Rho proteins, thus impacting multiple Rho-mediated signaling pathways and cellular processes that are pivotal for Rho T1's function. CID-1067700, by broadly targeting GTPase signaling and binding to Rho GEFs, exemplify the broad-spectrum approach in inhibiting Rho T1. In summary, the chemical class of Rho T1 inhibitors is characterized by their diverse mechanisms of action, each targeting different aspects of the Rho T1-associated signaling pathways. By modulating these pathways, these inhibitors influence the activity of Rho T1, reflecting the intricate network of cellular signaling and regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of ROCK, a downstream effector of Rho. Inhibition of ROCK by Y-27632 can disrupt Rho-mediated signaling, potentially leading to the indirect inhibition of Rho T1 by altering the actin cytoskeleton dynamics and cell motility. | ||||||
CCG-1423 | 285986-88-1 | sc-205241 sc-205241A | 1 mg 5 mg | $30.00 $90.00 | 8 | |
CCG-1423 targets the Rho/MRTF/SRF transcription pathway. By inhibiting this pathway, CCG-1423 can disrupt gene expression regulated by Rho, potentially leading to the indirect inhibition of Rho T1 through altered cellular responses to Rho signaling. | ||||||
Rhosin | 1173671-63-0 | sc-507401 | 25 mg | $555.00 | ||
Rhosin directly binds to Rho and inhibits its interaction with GEFs, thereby blocking Rho activation. This inhibition can lead to the indirect modulation of Rho T1 by disrupting upstream Rho signaling and its associated cellular functions. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is a selective inhibitor of Cdc42, a Rho family GTPase. By inhibiting Cdc42, ML141 can influence Rho-mediated signaling pathways, potentially leading to the indirect inhibition of Rho T1 through changes in actin organization and cell morphology. | ||||||
ITX 3 | 347323-96-0 | sc-295214 sc-295214A | 10 mg 50 mg | $145.00 $615.00 | ||
ITX3 is an inhibitor of Trio, a Rho GEF. By inhibiting Trio, ITX3 can disrupt Rho GTPase signaling, potentially leading to the indirect inhibition of Rho T1 through altered regulation of cytoskeletal dynamics. | ||||||
CASIN | 425399-05-9 | sc-397016 | 10 mg | $460.00 | 1 | |
CASIN inhibits Cdc42 activation. By targeting Cdc42, CASIN can modulate Rho GTPase signaling pathways, potentially leading to the indirect inhibition of Rho T1 through changes in cell shape, migration, and polarity. | ||||||
2-(Benzoylcarbamothioylamino)-5,5-dimethyl-4,7-dihydrothieno[2,3-c]pyran-3-carboxylic Acid | 314042-01-8 | sc-503400 | 10 mg | $300.00 | ||
This compound is a general inhibitor of GTPase signaling. By broadly targeting GTPases, it can disrupt Rho family signaling, potentially leading to the indirect inhibition of Rho T1 through altered cellular signaling pathways. | ||||||